Fig. 1
From: Urine proteomics identifies biomarkers for diabetic kidney disease at different stages
Urine proteomic analysis of Diabetes, DKD, and CKD. a Clinical stages and the number of samples used in the discovery and validation datasets. b Principal component analysis of the proteomics data. Each dot represents an urinary sample. Blue: Diabetes, Yellow: DKD, Red: CKD. c Reactome pathway analysis of the disease-specific DEPs (323 DEPs for diabetes, 98 DEPs for DKD, 88 DEPs for CKD). d Pearson correlation coefficients between the abundance of the 2,946 urine proteins and the 13 routinely tested clinical or health indexes. e. Scatter plots of selected high abundance urine proteins and kidney function indexes with strong positive correlations